Journal of Nuclear Medicine

[177Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.
Journal of Nuclear MedicineOpinion

A Cures Act–Forged Pathway to Patient-Tailored Radiopharmaceutical Therapy and Call for Regulatory Transparency

Radiopharmaceutical therapy (RPT) offers molecular-targeted treatment strategies and presents an ideal model for advancing ...
Journal of Nuclear Medicine

Making a Career to Fight Cancer

Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...
snmjournals.org

Immunotheranostics in Solid Tumors: Longitudinal Tracking of Human IL13Rα2 CAR-T Cells In Vivo

Journal of Nuclear Medicine December 2025, jnumed.125.271365; DOI: https://doi.org/10.2967/jnumed.125.271365 ...
snmjournals.org

Radiopharmaceutical Therapy: Rapid Growth, Rising Challenges, and the Critical Need for Expertise

Journal of Nuclear Medicine October 2025, jnumed.125.271028; DOI: https://doi.org/10.2967/jnumed.125.271028 ...
snmjournals.org

Influence of Ultra-Low-Dose CT on PET Image Quantification and Visual Assessment

Journal of Nuclear Medicine October 2025, jnumed.124.269188; DOI: https://doi.org/10.2967/jnumed.124.269188 ...
snmjournals.org

Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last

Journal of Nuclear Medicine September 2025, jnumed.125.270358; DOI: https://doi.org/10.2967/jnumed.125.270358 ...
snmjournals.org

Clinical Validation of Deep Learning for Image Restoration of Ultra-Low-Count

Journal of Nuclear Medicine August 2025, jnumed.124.269234; DOI: https://doi.org/10.2967/jnumed.124.269234 ...
snmjournals.org

CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma

Journal of Nuclear Medicine July 2025, jnumed.125.270167; DOI: https://doi.org/10.2967/jnumed.125.270167 ...
snmjournals.org

Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine July 2025, jnumed.125.269729; DOI: https://doi.org/10.2967/jnumed.125.269729 ...
snmjournals.org

Novel Histamine Subtype 3 Receptor (H3R) PET Ligands for Brain Imaging

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 251600; ...
snmjournals.org

Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study

Journal of Nuclear Medicine May 2025, jnumed.125.269533; DOI: https://doi.org/10.2967/jnumed.125.269533 ...